#USA #Class Action #St. Louis #Monsanto #glyphosate

Overview of the Class Action Settlement on Glyphosate

In a significant judicial decision, the St. Louis Circuit Court in Missouri has granted preliminary approval for a proposed $7.25 billion class action settlement in the case of King v. Monsanto Company. This proposed settlement primarily addresses claims related to health issues, specifically non-Hodgkin lymphoma, attributed to exposure to glyphosate-based herbicides such as Roundup®. The court also sanctioned a comprehensive notification program aimed at educating potential claimants about their rights and options under the proposed settlement.

Details of the Settlement

The settled claims arise from allegations that prolonged exposure to glyphosate, particularly among agricultural workers—such as farmers and landscapers—could lead to the development of non-Hodgkin lymphoma, a type of blood cancer that may manifest several years post-exposure, often around 10 to 15 years later. Notably, Monsanto denies any damaging claims related to glyphosate and maintains that they are not liable for the alleged health risks; the court has not made any determinations regarding the merits of these claims at this stage.

Christopher Seeger, representing the plaintiffs from Seeger Weiss LLP, emphasized that the settlement is designed to ensure that individuals diagnosed with non-Hodgkin lymphoma due to glyphosate exposure can receive proper protection and compensation without enduring the long delays of further litigation.

Eric D. Holland from The Holland Law Firm highlighted the importance of this settlement by noting it provides peace of mind and compensation for the victims and their families, who have been waiting for a resolution for many years. This agreement also aims to protect the victims, ensuring they receive compensation over the next two decades.

Who is Included in the Settlement?

The settlement class encompasses a broad range of individuals, primarily including farmers, landscapers, grounds maintenance workers, and others who have been exposed to glyphosate-based herbicides like Roundup® in the United States before February 17, 2026. Individuals diagnosed with non-Hodgkin lymphoma following such exposure may qualify for benefits, as well as those who have been exposed but have not yet been diagnosed. Family members and representatives of deceased, minor, or incapacitated members of the class are also eligible to seek compensation.

Compensation Amounts

Eligible individuals diagnosed with non-Hodgkin lymphoma may receive compensation ranging from $6,000 to potentially over $165,000. The compensation varies mainly based on the type of exposure (home-based or workplace), age at diagnosis, and specific type of non-Hodgkin lymphoma diagnosed. Monsanto has committed to funding this settlement, with payments dispersed over a timeframe of 17 to 21 years.

Critical Deadlines

• - Opt-Out Deadline: Individuals who wish to retain the right to file a separate lawsuit against Monsanto must submit a written request to opt-out by June 4, 2026.
• - Objection Deadline: Members of the settlement class wishing to object to any part of the settlement must submit their written objections by June 4, 2026.
• - Final Approval Hearing: A hearing to determine if the proposed settlement is fair and reasonable is scheduled for July 9, 2026.

It’s noteworthy that these dates may change without further notice, and class members can obtain updated information via the settlement website.

How to Get More Information

Class members can find detailed notifications, the full settlement document, and other crucial materials at WeedKillerClass.com. Alternatively, they can call 1-888-403-8201 or email [email protected] for inquiries.

This article serves as an overview; comprehensive details regarding eligibility, benefits, deadlines, and rights are outlined in the court-approved notices and on the settlement website. The settlement will only become effective upon final court approval and after resolving any potential appeals.